Influence of physical exercise and relationship with biochemical variables of NT-pro-brain natriuretic peptide and ischemia modified albumin.

[1]  G. Lippi,et al.  Albumin cobalt binding and ischemia modified albumin generation: an endogenous response to ischemia? , 2006, International journal of cardiology.

[2]  H. Tschan,et al.  Responses of N-Terminal Pro-Brain Natriuretic Peptide (NT-proBNP) and Cardiac Troponin I (cTnI) to Competitive Endurance Exercise in Recreational Athletes , 2005, International journal of sports medicine.

[3]  R. D. de Winter,et al.  Ischemia-modified albumin measurements in symptom-limited exercise myocardial perfusion scintigraphy reflect serum albumin concentrations but not myocardial ischemia. , 2005, Clinical chemistry.

[4]  S. Williams,et al.  Complementary roles of simple variables, NYHA and N-BNP, in indicating aerobic capacity and severity of heart failure. , 2005, International journal of cardiology.

[5]  C. Hengstenberg,et al.  Effect of Compensated Renal Dysfunction on Approved Heart Failure Markers: Direct Comparison of Brain Natriuretic Peptide (BNP) and N-Terminal Pro-BNP , 2005, Hypertension.

[6]  G. Guyatt,et al.  Capability of ischemia-modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome , 2005, Canadian Medical Association Journal.

[7]  L. Køber,et al.  N-Terminal Pro-B-Type Natriuretic Peptide and Long-Term Mortality in Stable Coronary Heart Disease , 2005 .

[8]  R. S. Foote,et al.  Can exercise-induced changes in B-type natriuretic peptides be used to detect cardiac ischemia? , 2005, Journal of cardiac failure.

[9]  L. Køber,et al.  N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. , 2005, The New England journal of medicine.

[10]  R. Razzolini,et al.  Correlations between clinical presentation, brain natriuretic peptide, big endothelin-1, tumor necrosis factor-alpha and cardiac troponins in heart failure patients. , 2005, Italian heart journal : official journal of the Italian Federation of Cardiology.

[11]  G. Lippi,et al.  High-workload endurance training may increase serum ischemia-modified albumin concentrations , 2005, Clinical chemistry and laboratory medicine.

[12]  K. Lewandrowski,et al.  Ischemia-modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting. , 2005, American journal of clinical pathology.

[13]  Pablo Avanzas,et al.  Ischemia Modified Albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. , 2004, International journal of cardiology.

[14]  W. Herrmann,et al.  No difference in N-terminal pro-brain natriuretic peptide (NT-proBNP) concentrations between endurance athletes with athlete’s heart and healthy untrained controls , 2004, Heart.

[15]  J. Kaski,et al.  Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia. , 2004, Clinical chemistry.

[16]  T. Marwick,et al.  Response of B-type natriuretic peptide to exercise in hypertensive patients with suspected diastolic heart failure: correlation with cardiac function, hemodynamics, and workload. , 2004, American heart journal.

[17]  T. Fukui,et al.  Is B-type natriuretic peptide-guided heart failure management cost-effective? , 2004, International journal of cardiology.

[18]  J. Ordóñez‐Llanos,et al.  Ischemia-modified albumin during skeletal muscle ischemia. , 2004, Clinical chemistry.

[19]  U. Janssens,et al.  Brain natriuretic peptide kinetics during dynamic exercise in patients with chronic heart failure. , 2004, International journal of cardiology.

[20]  K. George,et al.  Myocardial stress after competitive exercise in professional road cyclists. , 2004, Medicine and science in sports and exercise.

[21]  O. Nyvad,et al.  Effect of exercise on natriuretic peptides in plasma and urine in chronic heart failure. , 2004, International journal of cardiology.

[22]  G. Lippi,et al.  Comparison of serum creatinine, uric acid, albumin and glucose in male professional endurance athletes compared with healthy controls , 2004, Clinical Chemistry and Laboratory Medicine.

[23]  A. Kjær,et al.  Basal and exercise‐induced neuroendocrine activation in patients with heart failure and in normal subjects , 2004, European journal of heart failure.

[24]  J. Hollander,et al.  Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study. , 2003, American heart journal.

[25]  Wen-Sheng Huang,et al.  Circulating brain natriuretic peptide values in healthy men before and after exercise. , 2002, Metabolism: clinical and experimental.

[26]  F. Apple,et al.  Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race. , 2002, Clinical chemistry.

[27]  M. Plebani Biochemical markers of cardiac damage: from efficiency to effectiveness. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[28]  J. Mair,et al.  The Impact of Cardiac Natriuretic Peptide Determination on the Diagnosis and Management of Heart Failure , 2001, Clinical chemistry and laboratory medicine.

[29]  M. Murayama,et al.  Effects of prolonged strenuous exercise on plasma levels of atrial natriuretic peptide and brain natriuretic peptide in healthy men. , 2001, American heart journal.

[30]  L. Stefani,et al.  Effects of exercise on natriuretic peptides and cardiac function in man. , 1998, International journal of cardiology.

[31]  R. Myerburg,et al.  Sudden Death in Athletes , 1998, Sports medicine.

[32]  H. Itoh,et al.  Rapid ventricular induction of brain natriuretic peptide gene expression in experimental acute myocardial infarction. , 1995, Circulation.

[33]  A. D. de Bold,et al.  A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. , 1981, Life sciences.